《【美国女性健康生物医学创新公司】FEMASYS INC（FEMY）美股招股说明书 S-1（2025-08-20首版）（英文版）（39页）.pdf》由会员分享，可在线阅读，更多相关《【美国女性健康生物医学创新公司】FEMASYS INC（FEMY）美股招股说明书 S-1（2025-08-20首版）（英文版）（39页）.pdf（39页珍藏版）》请在三个皮匠报告上搜索。

1、S-1 1 ny20053452x3_s1.htm S-1TABLE OF CONTENTSRegistration No.333-As filed with the Securities and Exchange Commission on August 19,2025UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM S-1REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933Femasys Inc.(Exact name of registr

2、ant as specified in its charter)Delaware 3841 11-3713499(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)3950 Johns Creek Court,Suite 100Suwanee,Georgia 30024(770)500-3910(Address,including zip code,

3、and telephone number,including area code,of registrants principal executive offices)Kathy Lee-SepsickPresident and Chief Executive Officer3950 Johns Creek Court,Suite 100Suwanee,Georgia 30024(770)500-3910(Name,address,including zip code,and telephone number,including area code,of agent for service)W

4、ith a copy to:David S.Rosenthal,Esq.Anna Tomczyk,Esq.Dechert LLP1095 Avenue of AmericasNew York,New York 10036(212)698-3616Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of thisregistration statement.If any of the securities being regi

5、stered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under theSecurities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check the followingbox and list

6、the Securities Act registration statement number of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and list theSecurities Act registration statement number of